Cardiovascular Disease (CVD) Completed Phase 3 Trials for Dapagliflozin (DB06292)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01031680Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionTreatment
NCT01042977Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseTreatment